$ Value
$539K
Shares
11,538
Price
$47
Filed
Feb 12
Insider
Name
Smith Thomas B
Title
EVP and Chief Medical Officer
CIK
0001748462
Roles
Transaction Details
Transaction Date
2026-02-10
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
90,651
Footnotes
Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2027, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. | Includes 376 and 404 shares acquired on July 18, 2025 and January 16, 2026, respectively, under the Issuer's employee stock purchase plan. | Effective February 10, 2026, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 22,774 performance share units ("PSUs") granted in the Issuer's three prior fiscal years. | Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs. | Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs.
Filing Info
Smith Thomas B's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-10 | COLL | A | $0 |
| 2026-02-10 | COLL | A | $0 |
| 2026-02-10 | COLL | F | $276K |
| 2026-02-10 | COLL | F | $539K |
| 2025-08-29 | COLL | ▼ | $672K |
Other Insiders at COLL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Karnani Vikram
President and CEO
|
— | — | 2026-02-10 |
|
Dreyer Scott
EVP & Chief Commercial Officer
|
— | $2.0M | 2026-03-03 |
|
Smith Thomas B
EVP and Chief Medical Officer
|
— | — | 2026-02-10 |
|
Tupper Colleen
EVP & Chief Financial Officer
|
— | — | 2026-02-10 |
|
Dieter David
EVP & General Counsel
|
— | — | 2026-03-17 |